Lions and Tigers and Bears Oh My! SEROQUEL XR formulation patent obvious
On March 7, 2013, Justice Near of the Federal Court of Canada, dismissed AstraZeneca’s prohibition applications against Teva in respect quetiapine fumarate... Read More
US Court upholds validity of quetiapine formulation patent (SEROQUEL XR)
On March 28, 2012, the U.S. District Court for the District of New Jersey, in a 100 page opinion, held that AstraZeneca’s... Read More
Quetiapine Formulation Patent Obvious – U.K. High Court
On March 22, 2012, the U.K. High Court of Justice, Chancery Division held that AstraZeneca’s patent covering an sustained release formulation of... Read More